Dynavax Technologies Corp financial data

Symbol
DVAX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2100 Powell Street, Suite 720, Emeryville, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.41K % +41.6%
Quick Ratio 95.8 % +48.6%
Debt-to-equity 58.4 % -11.7%
Return On Equity 3.19 % -69.6%
Return On Assets 2.02 % -68.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 131M shares +1.7%
Common Stock, Shares, Outstanding 131M shares +1.66%
Entity Public Float 900M USD -18.2%
Common Stock, Value, Issued 131K USD +1.55%
Weighted Average Number of Shares Outstanding, Basic 131M shares +1.66%
Weighted Average Number of Shares Outstanding, Diluted 155M shares +0.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 261M USD -27.8%
Research and Development Expense 57M USD +6.3%
Costs and Expenses 272M USD -16.8%
Operating Income (Loss) -11M USD -132%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 24.2M USD -61.3%
Income Tax Expense (Benefit) 3.75M USD +152%
Net Income (Loss) Attributable to Parent 20.5M USD -66.5%
Earnings Per Share, Basic 0.15 USD/shares -69.4%
Earnings Per Share, Diluted 0.14 USD/shares -64.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 119M USD -22.8%
Inventory, Net 62.4M USD +26.3%
Assets, Current 926M USD +10.8%
Property, Plant and Equipment, Net 37.4M USD +3.42%
Operating Lease, Right-of-Use Asset 21.8M USD -12.7%
Goodwill 2.09M USD +5.55%
Other Assets, Noncurrent 74.5M USD +0.41%
Assets 1.06B USD +9.15%
Accounts Payable, Current 7.09M USD +127%
Accrued Liabilities, Current 54.1M USD +24.5%
Liabilities, Current 70M USD +29.1%
Operating Lease, Liability, Noncurrent 26.6M USD -13.3%
Other Liabilities, Noncurrent 28K USD -91.3%
Liabilities 381M USD +3.41%
Accumulated Other Comprehensive Income (Loss), Net of Tax 514K USD
Retained Earnings (Accumulated Deficit) -910M USD +2.2%
Stockholders' Equity Attributable to Parent 681M USD +12.6%
Liabilities and Equity 1.06B USD +9.15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.7M USD -160%
Net Cash Provided by (Used in) Financing Activities -4.2M USD -36%
Net Cash Provided by (Used in) Investing Activities 2.83M USD
Common Stock, Shares Authorized 278M shares 0%
Common Stock, Shares, Issued 131M shares +1.66%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.3M USD +34%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 120M USD -22.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 180M USD +0.82%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.24 pure +677%
Deferred Tax Assets, Gross 189M USD +0.38%
Operating Lease, Liability 31M USD -11.5%
Payments to Acquire Property, Plant, and Equipment 749K USD -41.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 27M USD -58.2%
Lessee, Operating Lease, Liability, to be Paid 42.4M USD -14.7%
Property, Plant and Equipment, Gross 69.1M USD +6.16%
Operating Lease, Liability, Current 4.42M USD +0.75%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.13M USD -11.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.99M USD -7.81%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.4M USD -22.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.06M USD -0.61%
Deferred Tax Assets, Operating Loss Carryforwards 96.3M USD -14.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 12.1M USD +6.72%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.22M USD +3.25%
Operating Lease, Payments 1.9M USD +11.8%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 9.04M USD -7.71%
Share-based Payment Arrangement, Expense 0 USD -100%
Interest Expense 6.78M USD +0.49%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%